⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Enhancing Anesthetic Preoptimization: Promising Opportunities for Innovation in Economically Diverse Regions

Authors: Bernstein WK et al. Anesthesia & Analgesia, 142(1):76–84, January 2026 This article is a roadmap for how anesthesiologists can drive higher-value perioperative care by moving “upstream” into preoperative optimization, especially in regions where resources and access vary (rural/urban underserved as well as higher-resource settings). The authors argue perioperative costs are rising unsustainably, and that […]

Returning to Anesthesia After Burnout, Pain Management, ICU med or administrative job? We Built a Path Back

Burnout or time away in pain, ICU, or administration doesn’t erase your anesthesia training—it just requires a structured path back. For many physicians, it simply means you stepped away to regroup. We work with anesthesiologists every day who want to return to clinical anesthesia after time away in: administration or leadership roles pain medicine critical […]

BEST Independent CRNA Opportunity – Savannah, TN just increased salary $15,000

Moisture, Mold, and More in GE Operating Room Ventilators: System Response and Mitigation

Authors: Narayan S et al. Anesthesia Patient Safety Foundation Newsletter, volume 41, number 1, February 2026. SummaryThis article describes a system-wide response to reports of moisture accumulation and mold-like debris within certain GE HealthCare anesthesia workstations, focusing on patient safety risk assessment, root-cause analysis, mitigation strategies, and lessons for perioperative teams. The report originates from […]

Intranasal naloxone reversal of opioid-induced respiratory depression in opioid-naïve individuals and self-reported daily opioid users

Authors: van Lemmen MA et al. Anesthesiology, February 5, 2026 Summary With opioid overdose deaths increasingly driven by potent synthetic opioids such as fentanyl and carfentanil, understanding the real-world effectiveness of intranasal naloxone is critical. This prospective crossover trial evaluated whether a single 4 mg dose of intranasal naloxone (Narcan®) effectively reverses moderate respiratory depression […]